血管肉瘤治療市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、治療方法、最終用戶、地區和競爭格局分類，2020-2030年預測

2024年全球血管肉瘤治療市場規模為2.8011億美元，預計到2030年將以6.11%的複合年成長率成長至3.9985億美元。血管肉瘤治療涵蓋一系列治療策略，包括手術、放射療法、化療和標靶藥物療法，這些療法在各種醫療機構中均有應用，用於治療這種侵襲性強且罕見的癌症。市場擴張的根本驅動力是全球血管肉瘤病例的不斷增加，這促使人們需要更先進的治療方法。

主要市場促進因素

全球血管肉瘤治療市場受到血管肉瘤發生率上升的顯著影響。這種侵襲性強的罕見癌症發生率顯著增加，從而擴大了需要治療干預的患者群體。

主要市場挑戰

全球血管肉瘤治療市場擴張的一大障礙是缺乏標準化的治療方案。血管肉瘤本身的罕見性和異質性導致缺乏普遍接受的臨床指南，造成不同醫療機構間患者治療方案有顯著差異。

主要市場趨勢

免疫療法的應用日益廣泛，是全球血管肉瘤治療市場的一大趨勢，它利用患者自身的免疫系統對抗癌症。對於血管肉瘤這類侵襲性強、罕見的癌症，傳統療法往往療效有限，因此免疫療法至關重要。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球血管肉瘤治療市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依類型（血管肉瘤、淋巴管肉瘤、實質血管肉瘤）
  • 依治療方法（手術、放射線治療、化學療法、標靶治療、免疫療法、其他）
  • 依最終使用者（醫院和診所、門診手術中心、線上藥局）分類
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美血管肉瘤治療市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲血管肉瘤治療市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區血管肉瘤治療市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲血管肉瘤治療市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲血管肉瘤治療市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章：全球血管肉瘤治療市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Novartis AG
• Bayer AG
• Sanofi AG
• Amgen Inc
• Eli Lilly and Company
• Genentech Inc.
• Janssen Pharmaceuticals
• AbbVie Inc
• Bausch Health Companies Inc.
• GlaxoSmithKline Plc

第16章：策略建議

第17章調查會社について,免責事項

The Global Angiosarcoma Treatment Market , valued at USD 280.11 Million in 2024, is projected to experience a CAGR of 6.11% to reach USD 399.85 Million by 2030. Angiosarcoma treatment encompasses a range of therapeutic strategies, including surgery, radiation therapy, chemotherapy, and targeted drug therapies, employed across various healthcare settings to manage this aggressive and rare cancer. The market's expansion is fundamentally driven by the increasing incidence of angiosarcoma cases globally, necessitating advanced therapeutic interventions.

Key Market Drivers

The global angiosarcoma treatment market is significantly influenced by the rising incidence of angiosarcoma cases. This aggressive rare cancer has demonstrated a notable increase in its occurrence, thereby expanding the patient population requiring therapeutic intervention. According to a study published in JAMA Network Open in April 2024, the U. S. incidence of angiosarcoma doubled from 657 newly diagnosed cases in 2001 to 1312 cases in 2019.

Key Market Challenges

A significant impediment to the expansion of the Global Angiosarcoma Treatment Market is the persistent lack of standardized treatment protocols. The inherent rarity and heterogeneous nature of angiosarcoma contribute to an absence of universally accepted clinical guidelines, resulting in considerable variability in patient care across institutions. This inconsistency directly hampers the development and adoption of advanced therapeutic interventions.

Key Market Trends

The expanding application of immunotherapy is a significant trend in the global angiosarcoma treatment market, leveraging the patient's immune system against cancer. This approach is vital for aggressive, rare cancers like angiosarcoma, where traditional therapies often have limited success. Research into tumor immunology has advanced, leading to innovative immune checkpoint inhibitors.

Key Market Players

• Novartis AG
• Bayer AG
• Sanofi AG
• Amgen Inc
• Eli Lilly and Company
• Genentech Inc.
• Janssen Pharmaceuticals
• AbbVie Inc
• Bausch Health Companies Inc.
• GlaxoSmithKline Plc

Report Scope:

In this report, the Global Angiosarcoma Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Angiosarcoma Treatment Market , By Type:

• Hemangiosarcoma
• Lymphangiosarcoma
• Parenchymal Angiosarcoma

Angiosarcoma Treatment Market , By Treatment:

• Surgery
• Radiotherapy
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Others

Angiosarcoma Treatment Market , By End user:

• Hospital & Clinics
• Ambulatory Surgical Centers
• Online Pharmacies

Angiosarcoma Treatment Market , By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Angiosarcoma Treatment Market .

Available Customizations:

Global Angiosarcoma Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Angiosarcoma Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Hemangiosarcoma, Lymphangiosarcoma, Parenchymal Angiosarcoma)
  • 5.2.2. By Treatment (Surgery, Radiotherapy, Chemotherapy, Targeted Therapy, Immunotherapy, Others)
  • 5.2.3. By End user (Hospital & Clinics, Ambulatory Surgical Centers, Online Pharmacies)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Angiosarcoma Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Treatment
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Angiosarcoma Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Treatment
      • 6.3.1.2.3. By End user
  • 6.3.2. Canada Angiosarcoma Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Treatment
      • 6.3.2.2.3. By End user
  • 6.3.3. Mexico Angiosarcoma Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Treatment
      • 6.3.3.2.3. By End user

7. Europe Angiosarcoma Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Treatment
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Angiosarcoma Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Treatment
      • 7.3.1.2.3. By End user
  • 7.3.2. France Angiosarcoma Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Treatment
      • 7.3.2.2.3. By End user
  • 7.3.3. United Kingdom Angiosarcoma Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Treatment
      • 7.3.3.2.3. By End user
  • 7.3.4. Italy Angiosarcoma Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Treatment
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Angiosarcoma Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Treatment
      • 7.3.5.2.3. By End user

8. Asia Pacific Angiosarcoma Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Treatment
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Angiosarcoma Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Treatment
      • 8.3.1.2.3. By End user
  • 8.3.2. India Angiosarcoma Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Treatment
      • 8.3.2.2.3. By End user
  • 8.3.3. Japan Angiosarcoma Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Treatment
      • 8.3.3.2.3. By End user
  • 8.3.4. South Korea Angiosarcoma Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Treatment
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Angiosarcoma Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Treatment
      • 8.3.5.2.3. By End user

9. Middle East & Africa Angiosarcoma Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Treatment
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Angiosarcoma Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Treatment
      • 9.3.1.2.3. By End user
  • 9.3.2. UAE Angiosarcoma Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Treatment
      • 9.3.2.2.3. By End user
  • 9.3.3. South Africa Angiosarcoma Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Treatment
      • 9.3.3.2.3. By End user

10. South America Angiosarcoma Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Treatment
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Angiosarcoma Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Treatment
      • 10.3.1.2.3. By End user
  • 10.3.2. Colombia Angiosarcoma Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Treatment
      • 10.3.2.2.3. By End user
  • 10.3.3. Argentina Angiosarcoma Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Treatment
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Angiosarcoma Treatment Market : SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Novartis AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bayer AG
• 15.3. Sanofi AG
• 15.4. Amgen Inc
• 15.5. Eli Lilly and Company
• 15.6. Genentech Inc.
• 15.7. Janssen Pharmaceuticals
• 15.8. AbbVie Inc
• 15.9. Bausch Health Companies Inc.
• 15.10. GlaxoSmithKline Plc

16. Strategic Recommendations

17. About Us & Disclaimer